Clinical Observation of Chinese Drugs in Prevention of Neonatal Hyperbilirubinemia

£5.50
VAT Exempt
In stock
SKU
JTCM-841

JTCM September 1997 56/46
Zhuo Anshan et. al.

(Archive subscribers please click on 'find out more' to see abstract. The full article is not available online and must be bought as a photocopy delivered by post).

To read the full abstract subscribe to the JCM online archive

Clinical Observation of Chinese Drugs in Prevention of Neonatal Hyperbilirubinemia

Zhuo Anshan et. al.

It is reported that 50% of full term babies and 80% of premature babies may suffer from ...

More Information
Author Zhuo Anshan et al
Write Your Own Review
You're reviewing:Clinical Observation of Chinese Drugs in Prevention of Neonatal Hyperbilirubinemia
Your Rating

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.